Bio-Rad Laboratories, Inc. (BIO) Operating income 2016–2025
Bio-Rad Laboratories, Inc. (BIO) annual operating income history from SEC filings — each fiscal year as reported.
$47.2MFY2025 · since FY2016: $55.7M → $47.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $47.2M | -82.5% |
| FY2024 | $269.0M | -20.4% |
| FY2023 | $337.8M | -30.0% |
| FY2022 | $482.6M | -3.5% |
| FY2021 | $500.3M | +18.8% |
| FY2020 | $421.3M | +83.5% |
| FY2019 | $229.7M | +322.2% |
| FY2018 | -$103.3M | -186.7% |
| FY2017 | $119.3M | +114.0% |
| FY2016 | $55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice